Resverlogix Corp. RVXCF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

17/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Resverlogix Corp. (RVXCF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 16/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

17/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

✗

成长

15/100

→ Income

—

收入

N/A

No coverage

估值概览 — RVXCF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.03

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-0.69	$0.00	$-55.1M	-
2014	$-0.22	$0.00	$-18.32M	-
2015	$-0.20	$0.00	$-19.72M	-
2016	$-0.44	$0.00	$-46.21M	-
2017	$-0.42	$0.00	$-58.31M	-
2018	$-0.87	$0.00	$-162.8M	-
2019	$0.54	$0.00	$118.03M	-
2021	$-0.10	$0.00	$-24.77M	-
2022	$-0.01	$0.00	$-3.61M	-
2024	$-0.03	$0.00	$-7.64M	-